You are here

Home » Content

Tip 2 Diyabetli Hastalarda Metabolik Sendrom Prevalansı

Prevalence of Metabolic Syndrome In Type 2 Diabetic Patients

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Aim: This study was carried out to evaluate the prevalence of metabolic syndrome in type 2 diabetic patients. Material and method: A total 112 patients with type 2 diabetes who admitted to outpatient clinic of internal medicine in Malatya Doğanşehir Public Hospital were evaluated for metabolic syndrome by measuring of the waist circumference, arterial blood pressure, the level of triglycerides and HDL. Results: Patient group included total 112 type 2 diabetic patients, of these, 29 were male (25,9 %) and 83 were female (74,1 %). The prevalence of metabolic syndrome was 80,4 %. Male to female ratio was 62,1% / 86,7%. The prevalence of metabolic syndrome in type 2 diabetic female patients was found to be significantly higher than that of type 2 diabetic male patients (p<0,01). Conclusion: The coincidence of diabetes and metabolic syndrome is frequent. Studies showed that the majority of the diabetic patients associated with the criteria of the metabolic syndrome. In contrast to this, diabetes without metabolic syndrome is not frequent and constitutes only some of the diabetic cases. Similar findings were attained in our study as well. Since the risk of cardiovascular disease is further increased in case of the coincidence of diabetes and metabolic syndrome, the evaluation of the type 2 diabetic patients for metabolic syndrome and early and effective treatment of both pathologies is particularly important.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Bu çalışma, tip 2 diyabetli hastalarda metabolik sendrom prevalansını değerlendirmek amacıyla yapılmıştır. Materyal ve Metod: Malatya Doğanşehir Devlet Hastanesi İç Hastalıkları Polikliniği’ne başvuran 112 tip 2 diyabetli hasta bel çevresi, arteryel kan basıncı, trigliserid ve HDL-kolesterol düzeyleri ölçülerek metabolik sendrom açısından değerlendirilmiştir. Bulgular: Çalışma grubu 29’u erkek (%25,9), 83’ü kadın (%74,1) olmak üzere toplam 112 tip 2 diyabetli hastadan oluşmaktadır. Metabolik sendrom prevalansı %80,4 olarak bulunmuştur. Bu oran erkeklerde %62,1, kadınlarda %86,7 olarak saptanmıştır. Tip 2 diyabetli kadınlarda metabolik sendrom prevalansı tip 2 diyabetli erkeklere göre anlamlı derecede daha yüksek bulunmuştur (p<0,01). Sonuç: Diyabet ile metabolik sendrom birlikteliği sıktır. Yapılan çalışmalarda diyabetli hastaların çoğunun metabolik sendrom kriterlerini taşıdığı görülmüştür. Metabolik sendrom olmayan diyabetik hasta sık değildir ve diyabetlilerin az bir kısmını oluşturmaktadır. Çalışmamızda da benzer bulgular elde edilmiştir. Tip 2 diyabet ve metabolik sendrom birlikte bulunduğunda kardiyovasküler hastalık riskini çok daha fazla arttığından, tip 2 diyabetli hastaların metabolik sendrom yönünden de değerlendirilmeleri ve her iki hastalığın erken ve etkin tedavisi büyük önem taşımaktadır.
FULL TEXT (PDF): 
PDF icon arastirmax-tip-2-diyabetli-hastalarda-metabolik-sendrom-prevalansi.pdf
  • 1
29-33
  • Turkish

REFERENCES

References: 

1. Gündoğdu AS. Metabolik sendrom, insülin direnci ve tip 2 diabetten korunma.
Diabet Esasları. Birinci baskı 2006;12-21.
2. Sanders BH, Lubsch LM, West DS. Prevalence and treatment of metabolic
syndrome in adolescents with type 2 diabetes. Ann Pharmacother 2006;40:1517-
21.
3. Tkac I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis.
Diabetes Research and Clinical Practice 2005;68:2-9.
4. Orna JAG, Arnal LML, Herguedas EM et al. Metabolic syndrome as a
cardiovascular risk factor in patients with type 2 diabetes. Rev Esp Cardiol
2004;57(6):507-13.
5. Alebiosu CO, Odusan BO. Metabolic syndrome in subject with type-2 diabetes
mellitus. J Natl Med Assoc. 2004;96:817-21.
6. Foucan L, Deloumeaux J, Donnet JP et al. Metabolic syndrome components in
Indian migrants with type 2 diabetes. Diabetes Metab 2006;32:337-42.
7. Najarian RM, Sullivan LM, Kannel WB et al. Metabolic syndrome compared with
type 2 diabetes mellitus as a risc factor for stroke. Arch Intern Med. 2006;166:106-
11.
8. Csaszar A, Kekes E, Abel T et al. Prevalence of metabolic syndrome estimated by
International Diabetes Federation criteria in a Hungarian population. Blood
Pressure. 2006;15:101-106.
9. Sanisoglu SY, Oktenli C, Hasimi A et al. Prevalence of metabolic syndromerelated
disorders in large adult population in Turkey. BMC Public Health 2006,
6:92.
10. Onat A, Ceyhan K, Basar O et al. Metabolic syndrome major impact on coronary
risk in a population with low cholesterol levels – A prospective and crosssectional
evaluation. Atherosclerosis 2002. 165:285-92.
11. Metabolik Sendrom Araştırma Grubu. METSAR sonuçları. XX. Ulusal
Kardiyoloji Kongresi. Antalya, 2004.
12. Hanley AJG, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus
with alternative definitions of the metabolic syndrome. Circulation.
2005;112:3713-21.
13. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic
syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in
coronary artery disease risk. The Journal of Clinical Endocrinology and
Metabolism. 2004;89:2601-7.
14. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality
associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
15. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP-defined metabolic
syndrome, diabetes and prevalence of coronary heart disease among NHANES
III participants age 50 years and older. Diabetes 2003;52:1210-4.

Thank you for copying data from http://www.arastirmax.com